A Tweak or Two

Howard Markel from the University of Michigan argues that it is time to re-think the Bayh-Dole Act. "A review of its origins and consequences supports the idea that policies governing the fast-changing worlds of medicine and biotechnology merit frequent reappraisal and reform," he writes at the New England Journal of Medicine.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

Put It in the Jar

Here You Go

Blisters for Science

Start With the Basics

Marrett To Leave NSF

In Science this week: mtDNA analysis give glimpse into decline of Neanderthals in Europe, and more.

The University of Arizona's Raina Maier writes that an understanding of the Earth's microbiome is needed.

The proposed Canadian budget emphasizes partnerships with industry, Nature News reports.

An Australian study of personalized medicine has run into problems as it recruits patients.